Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China
· Delayed Price · Currency is CNY 6.61
+0.23 (3.61%)
Jul 7, 2025, 3:04 PM CST
SHE:000952 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 603.38 | 635.05 | 730.11 | 794.85 | 785.1 | 686.91 | Upgrade
|
Other Revenue | 3.75 | 3.75 | 7.71 | 2.79 | 0.47 | 1.26 | Upgrade
|
| 607.13 | 638.8 | 737.82 | 797.64 | 785.57 | 688.17 | Upgrade
| |
Revenue Growth (YoY) | -24.36% | -13.42% | -7.50% | 1.54% | 14.15% | -5.90% | Upgrade
|
Cost of Revenue | 479.6 | 524.77 | 549.89 | 510.22 | 487.42 | 413.75 | Upgrade
|
Gross Profit | 127.53 | 114.03 | 187.93 | 287.42 | 298.15 | 274.42 | Upgrade
|
Selling, General & Admin | 262.84 | 263.03 | 194.83 | 149.94 | 137.29 | 138.52 | Upgrade
|
Research & Development | 51.63 | 56.82 | 74.75 | 68.98 | 52.06 | 38.77 | Upgrade
|
Other Operating Expenses | 18.96 | 14.03 | 12.92 | 13.5 | 15.97 | 13 | Upgrade
|
Operating Expenses | 330.63 | 331.08 | 282.64 | 236.3 | 210.87 | 190.44 | Upgrade
|
Operating Income | -203.1 | -217.04 | -94.7 | 51.13 | 87.28 | 83.97 | Upgrade
|
Interest Expense | -62.59 | -61.98 | -49.15 | -21.1 | -16.71 | -31.95 | Upgrade
|
Interest & Investment Income | 1.78 | 2.06 | 3.46 | 8.31 | 21.95 | 33.58 | Upgrade
|
Currency Exchange Gain (Loss) | 4.31 | 4.31 | 2.07 | 4.33 | -2.11 | -5.66 | Upgrade
|
Other Non Operating Income (Expenses) | -1.49 | -0.38 | -0.04 | -1.01 | 7.3 | -0.96 | Upgrade
|
EBT Excluding Unusual Items | -260.23 | -273.03 | -138.36 | 41.65 | 97.72 | 78.98 | Upgrade
|
Gain (Loss) on Sale of Investments | -27.92 | -27.92 | -10.02 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -2.49 | -2.4 | 0.25 | -4.31 | 0.54 | 0.18 | Upgrade
|
Asset Writedown | -28.17 | -30.68 | -0.12 | -0.14 | -0.01 | -0.46 | Upgrade
|
Legal Settlements | 1.04 | 1.04 | 0.9 | -0.75 | 5.55 | -5.55 | Upgrade
|
Other Unusual Items | 12.5 | 12.71 | 6.69 | 23.63 | 20.54 | 15 | Upgrade
|
Pretax Income | -305.28 | -320.29 | -140.67 | 60.08 | 124.34 | 88.15 | Upgrade
|
Income Tax Expense | -4.63 | -5.16 | 11.75 | 12.4 | 18.53 | 17.85 | Upgrade
|
Earnings From Continuing Operations | -300.64 | -315.13 | -152.41 | 47.68 | 105.81 | 70.3 | Upgrade
|
Minority Interest in Earnings | 19.6 | 19.84 | 12.17 | 2.65 | 4.3 | 4.35 | Upgrade
|
Net Income | -281.05 | -295.29 | -140.25 | 50.33 | 110.11 | 74.65 | Upgrade
|
Net Income to Common | -281.05 | -295.29 | -140.25 | 50.33 | 110.11 | 74.65 | Upgrade
|
Net Income Growth | - | - | - | -54.29% | 47.50% | -14.14% | Upgrade
|
Shares Outstanding (Basic) | 351 | 352 | 354 | 351 | 344 | 334 | Upgrade
|
Shares Outstanding (Diluted) | 351 | 352 | 354 | 353 | 344 | 334 | Upgrade
|
Shares Change (YoY) | -0.89% | -0.60% | 0.36% | 2.54% | 2.85% | 9.28% | Upgrade
|
EPS (Basic) | -0.80 | -0.84 | -0.40 | 0.14 | 0.32 | 0.22 | Upgrade
|
EPS (Diluted) | -0.80 | -0.84 | -0.40 | 0.14 | 0.32 | 0.22 | Upgrade
|
EPS Growth | - | - | - | -55.42% | 43.41% | -21.44% | Upgrade
|
Free Cash Flow | -87.62 | -154.28 | -715.1 | -158.63 | -20.7 | 21.49 | Upgrade
|
Free Cash Flow Per Share | -0.25 | -0.44 | -2.02 | -0.45 | -0.06 | 0.06 | Upgrade
|
Dividend Per Share | - | - | - | - | 0.060 | 0.060 | Upgrade
|
Dividend Growth | - | - | - | - | - | 2.92% | Upgrade
|
Gross Margin | 21.00% | 17.85% | 25.47% | 36.03% | 37.95% | 39.88% | Upgrade
|
Operating Margin | -33.45% | -33.98% | -12.83% | 6.41% | 11.11% | 12.20% | Upgrade
|
Profit Margin | -46.29% | -46.23% | -19.01% | 6.31% | 14.02% | 10.85% | Upgrade
|
Free Cash Flow Margin | -14.43% | -24.15% | -96.92% | -19.89% | -2.63% | 3.12% | Upgrade
|
EBITDA | -27.54 | -52.84 | 24.04 | 148.58 | 178.15 | 174.42 | Upgrade
|
EBITDA Margin | -4.54% | -8.27% | 3.26% | 18.63% | 22.68% | 25.35% | Upgrade
|
D&A For EBITDA | 175.56 | 164.2 | 118.75 | 97.45 | 90.87 | 90.44 | Upgrade
|
EBIT | -203.1 | -217.04 | -94.7 | 51.13 | 87.28 | 83.97 | Upgrade
|
EBIT Margin | -33.45% | -33.98% | -12.83% | 6.41% | 11.11% | 12.20% | Upgrade
|
Effective Tax Rate | - | - | - | 20.64% | 14.90% | 20.25% | Upgrade
|
Revenue as Reported | 607.13 | 638.8 | 737.82 | 797.64 | 785.57 | 688.17 | Upgrade
|
Advertising Expenses | - | 15.88 | 9.05 | 5.84 | 6.12 | 6.78 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.